Skip to main content
Premium Trial:

Request an Annual Quote

DRI Capital Acquires Rights to Nanogen Royalties

NEW YORK (GenomeWeb News) – DRI Capital will pay Nanogen $10 million for the rights to all future royalties under a licensing agreement between Nanogen and Applied Biosystems.
 
According to a joint announcement from the firms, DRI Capital will receive royalties related to Nanogen’s minor groove binder technology, which was licensed by ABI for use in certain TaqMan products. The MGB technology is used for the design of oligonucleotide probes.
 
“Monetizing this royalty stream provides us with a non-dilutive means of raising capital to fund our operations as we work towards achieving cash flow breakeven in late 2008,” said Howard Birndorf, chairman and CEO of San Diego-based Nanogen.
 
Earlier this month, Nanogen reported that its fourth quarter revenues had increased 13 percent, even though it had shut down its microarray business just a few months earlier. The firm also said that it expects its independent accountants to issue an adverse opinion with respect to its internal controls and say that “there is substantial doubt about the company’s ability to continue as a going concern.”
 
Nanogen had $5.8 million in cash and cash equivalents as of the end of 2007.
 
Nanogen also said last week in a filing with the US Securities and Exchange Commission that it will restate its 2007 financial statements due to adjustments in the way the firm accounts for its investment in Jurilab. It said the changes would not impact previously reported cash, short-term investments, or revenues.
 
Nanogen invested $1.5 million in the Finland-based pharmacogenomics firm in 2005 as part of an alliance to develop molecular diagnostics.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.